Surgery Partners, INC 8-K filings

Surgery Partners announced its second quarter 2026 financial results, reporting a 2.7% increase in revenue and reaffirming its full-year guidance, despite a net loss for the quarter.

Surgery Partners announced an agreement to sell its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health for approximately $795 million.

Surgery Partners, Inc. announced the results of its Annual Meeting, confirming the re-election of Class II directors and the approval of executive compensation and auditor ratification.

Surgery Partners announced its first quarter 2026 financial results, reporting a 4.5% increase in revenue and reaffirming its full-year guidance.

Surgery Partners, Inc. announced mixed fourth quarter and full year 2025 results, including a net loss, but provided 2026 guidance and authorized a $200 million share repurchase program.

Surgery Center Holdings, a wholly-owned subsidiary of Surgery Partners, Inc., has issued an additional $425 million in 7.250% Senior Notes due 2032.

Surgery Partners' subsidiary, Surgery Center Holdings, Inc., priced a $425 million offering of 7.250% senior unsecured notes due 2032, with proceeds intended for general corporate purposes and debt repayment.

Surgery Partners' subsidiary, Surgery Center Holdings, Inc., announced its intent to offer $425.0 million in 7.250% Senior Notes due 2032 for general corporate purposes, including debt repayment.

Surgery Partners, Inc. announced the appointment of Justin Oppenheimer as Chief Operating Officer and National Group President, effective January 1, 2026.

Surgery Partners, Inc. announced its third quarter 2025 results, reporting revenue and Adjusted EBITDA growth but revising full-year guidance downwards due to softer volume and payor mix trends.

Surgery Partners, Inc. announced the resignation of Harrison R. Bane, its National Group President, effective October 3, 2025.

Surgery Partners, Inc. has successfully refinanced its existing term loans and revolving credit commitments, securing new facilities totaling $1.38 billion with reduced interest rates.

Surgery Partners, Inc. announces the immediate resignation of Executive Chairman Wayne S. DeVeydt and the appointment of Blair E. Hendrix as the new Chairman, reducing the board size to 10 directors.

Surgery Partners, Inc. announced strong second quarter 2025 financial results, reaffirming its full-year 2025 revenue and Adjusted EBITDA guidance.

Surgery Partners, Inc. announced that its independent committee concluded discussions with Bain Capital, determining that the company's prospects as an independent public entity exceed the value of Bain Capital's acquisition proposal, while reaffirming its full-year 2025 financial guidance.

Surgery Partners, Inc. announced the results of its 2025 Annual Meeting of Stockholders, where all proposals, including the re-election of Class I directors and the approval of the 2025 Omnibus Incentive Plan, were passed.

Surgery Partners reports an 8.2% increase in revenue and reaffirms its full-year 2025 revenue and Adjusted EBITDA guidance.

Surgery Partners announces a 17.5% increase in Q4 revenue and provides 2025 revenue and Adjusted EBITDA guidance.

Surgery Partners has confirmed receiving a non-binding proposal from Bain Capital to acquire all outstanding shares not already owned by them for $25.75 per share.

Surgery Partners expands its board with the appointment of Dr. Laura L. Forese, bringing extensive healthcare experience to the company.

Surgery Partners announced a 14.3% increase in revenue and a 21.9% increase in adjusted EBITDA for the third quarter of 2024, while reaffirming its full-year guidance.

Surgery Partners Inc. has replaced its independent auditor, Deloitte & Touche LLP, with Ernst & Young LLP, effective August 21, 2024.

Surgery Partners reported strong second-quarter results, exceeding expectations with significant revenue and adjusted EBITDA growth, and subsequently raised its full-year 2024 guidance.

Surgery Partners has successfully amended its credit agreement, securing a new $1.4 billion term loan to refinance existing debt.

Surgery Partners Inc. successfully held its 2024 Annual Meeting, re-electing Class III directors, approving executive compensation, adopting an employee stock purchase plan, and ratifying the appointment of Deloitte & Touche LLP as its auditor.

Surgery Partners announced a 7.7% increase in revenue and an 8.2% increase in adjusted EBITDA for the first quarter of 2024, leading to an improved full-year outlook.

Surgery Partners, Inc. successfully completed the issuance and sale of $800 million in senior unsecured notes due 2032, using the proceeds to refinance existing debt.

Surgery Partners' subsidiary, Surgery Center Holdings, Inc., has priced an $800 million senior notes offering to refinance existing debt and fund future acquisitions.

Surgery Partners plans to offer $600 million in senior unsecured notes to redeem existing debt and fund future acquisitions.

Surgery Partners announced a robust 8% revenue increase for 2023 and a 15.2% jump in adjusted EBITDA, alongside a positive outlook for 2024.